Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Rouyer
P53 and PTEN Expression Contribute to the Inhibition of EGFR Downstream Signaling Pathway by Cetuximab
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Related publications
Inhibition of the Ras-Erk Pathway in Mitotic COS7 Cells Is Due to the Inability of EGFR/Raf to Transduce EGF Signaling to Downstream Proteins
Oncology Reports
Medicine
Cancer Research
Oncology
Involvement of Parp1 in the Downstream of P53 Dependent Signaling Pathway Induced After Gamma-Irradiation
Journal of Translational Science
The Phosphatase Inhibitor Menadione (Vitamin K3) Protects Cells From EGFR Inhibition by Erlotinib and Cetuximab
Clinical Cancer Research
Cancer Research
Oncology
Inhibition of RIG-I-Dependent Signaling to the Interferon Pathway During Hepatitis C Virus Expression and Restoration of Signaling by IKK
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Contact-Dependent Inhibition of EGFR Signaling by Nf2/Merlin
Journal of Cell Biology
Medicine
Cell Biology
Dual Kinase Inhibition of EGFR and HER2 Overcomes Resistance to Cetuximab in a Novel in Vivo Model of Acquired Cetuximab Resistance
Clinical Cancer Research
Cancer Research
Oncology
Pressure Suppresses Hepatocellular Glycogen Synthesis Through Activating the P53/Pten Pathway
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Inhibition of EGFR Signaling Protects From Mucormycosis
mBio
Virology
Microbiology
PTEN Loss Predicts Response to Notch Pathway Inhibition in Endometrial Cancer
Gynecologic Oncology
Gynecology
Oncology
Obstetrics